Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Report of Telephone Conversation, October 12, 2011 - Hemacord


Date/Time of Call:                      October 12, 2011 @ 2:00 A.M.  
CBER Representative:                     Mercy Quagraine, Mohommad Heidaran (DMPQ)
Organization Representative:       Pablo Rubenstein, Andromachi Scaradavou, Mike Zdanowski, Ludi Dobrila
Organization:                                    New York Blood Center Inc.
Subject:                                   Follow up on NYBC’s proposal for Retention Samples
STN:                                         125397/0
Telecon with NYBC October 12, 2011 2-3 PM:
Sponsor will send his written proposal via email and will wait for FDA response before initiating ‘Change Management Control’ to update their SOPs.
On a follow up question on their batch records approach, the agency (DMPQ) agreed with their approach. Regarding the status of their NDC #, Sponsor indicated that they were still in the process of securing the NDC #.

Page Last Updated: 09/24/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English